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Background
Nitric oxide (NO) is a short-lived, reactive molecule
generated by nitric oxide synthase (NOS). Three iso-
forms of NOS have been identified including: neuronal
NOS (NOS1), endothelial NOS (NOS3) and inducible
NOS (NOS2).
Objective
To identify expression of isoforms of NOS in nasal
polyps (NP) and normal nasal tissue, and to determine
if differences exist in NOS expression in NP rich in
eosinophils (Eo-hi) or with few eosinophils (Eo-low).
Methods
NP were obtained after endoscopic surgery for chronic
rhinosinusitis, and separated into two categories based
on eosinophil density. Nasal middle turbinates (MT)
were also collected as normal controls from patients
who had undergone surgery for pituitary adenomas. To
identify cell types expressing isoforms of NOS, double
immunostaining was performed using anti-NOS and
anti-leukocyte antibodies (e.g. mast cells [MC], eosino-
phils, T cells and macrophages).
Results
Expression of NOS isoforms in all cell types was greater
in NP than in MT. Number of NOS2 positive cells in
Eo-hi NP was higher than in Eo-low NP. However, there
were no differences in the numbers of NOS1 and NOS3
positive cells between Eo-hi and Eo-low NP. Both NOS2
positive MC and NOS2 positive Eo were significantly
greater in NP than in MT. In addition, the percentage of
NOS2 positive MC in Eo-hi NP was significantly higher
than in Eo-low NP.
Conclusion
Elevation in NOS2 expression in several cell types might
be an important factor in the life history of NP, espe-
cially those with an abundance of eosinophils.
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